Connexion
Connexion
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Inscription
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SOFTOX SOLUTIONS AS

(SOFTX)
Temps réel Oslo Bors  -  16:19 23/09/2022
26.90 NOK   -4.10%
05/09SoftOx Solutions AS annonce la fin de l'étude clinique de phase 1 de SBE pour le traitement des plaies chroniques
CI
01/09SoftOx Solutions AS annonce des changements de direction dans sa filiale, SoftOx Defense Solutions AS
CI
15/08SoftOx Solutions AS annonce ses résultats pour le deuxième trimestre et les six mois terminés le 30 juin 2022
CI
SynthèseCotationsGraphiquesActualitésAgendaSociétéFinancesDérivésFonds 
SynthèseToute l'actualitéAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur SOFTOX SOLUTIONS AS
05/09SoftOx Solutions Completes Early-stage Trial for Treatment of Chronic Wounds; Shares Dr..
05/09SOFTOX SOLUTIONS AS : Announces the end of the SBE Phase 1 clinical study for treatment of..
05/09SoftOx Solutions AS Announces the End of the SBE Phase 1 Clinical Study for Treatment o..
01/09SOFTOX SOLUTIONS AS : Strengthens its leadership team
01/09SoftOx Solutions AS Announces Executive Changes in its Subsidiary, SoftOx Defense Solut..
15/08SOFTOX : Presentation as of August 15.08.2022
15/08SOFTOX : Report Second Quarter 2022
15/08SOFTOX : Open and Download the Complete Second Quarter 2022 Report
15/08SOFTOX SOLUTIONS AS : Second quarter and half year results
15/08SoftOx Solutions AS Reports Earnings Results for the Second Quarter and Six Months Ende..
11/08SOFTOX SOLUTIONS AS : Invitation to the presentation of the 2Q 2022 results (update)
08/08SOFTOX SOLUTIONS AS : Invitation to the presentation of the 2Q 2022 results
20/07SOFTOX SOLUTIONS AS : Granted NOK 97 million from the European Defence Fund for the develo..
28/06SOFTOX SOLUTIONS AS : Clinical trial data published in Acta Dermato-Venereologica
28/06SoftOx Solution Starts Short-term Loan With Almhaug Bolig
28/06SoftOx Solutions AS Announces Clinical Trial Data Published in Acta Dermato-Venereologi..
13/06SoftOx Solutions AS notes the Norwegian Defence Research Establishment's (FFI) positive..
19/05SOFTOX SOLUTIONS AS : Announces positive phase 1 results for softox inhalation solution (s..
19/05SoftOx Solutions AS Announces Positive Phase 1 Results for SoftOx Inhalation Solution
18/05SOFTOX SOLUTIONS AS : to attend and host an educational symposium at the European Wound Ma..
12/05SOFTOX SOLUTIONS AS : Annual general meeting held
11/05SOFTOX SOLUTIONS AS : The SBE-01 phase 1 clinical study enters the final phase 1b
11/05SoftOx Solutions AS Announces the Last Patient Completes the Last Single-Dose Cohort of..
05/05SOFTOX SOLUTIONS AS : Notice of Annual General Meeting
04/05SOFTOX SOLUTIONS AS : Annual Report 2021
04/05SOFTOX : Guidelines for remuneration 2022_SoftOx Solutions AS
04/05SOFTOX : Articles of association 2022_SoftOx Solutions AS
04/05SOFTOX : 561276_Notice of Annual General Meeting 2022_SoftOx Solutions AS
04/05SOFTOX : Nomination committee recommentations 2022_SoftOx Solutions AS
28/04SOFTOX SOLUTIONS AS : Announces advancement into next phase (1b) in the SBE project
28/04Softox Solutions AS Announces Advancement into Next Phase (1B) in the SBE Project
28/04SoftOx Solutions AS Reports Earnings Results for the First Quarter Ended March 31, 2022
28/04SOFTOX : Open and Download Complete First Quarter 2022 Report
28/04SOFTOX SOLUTIONS AS : Results for the first quarter of 2022
21/04SOFTOX SOLUTIONS AS : Invitation to the presentation of the 1Q 2022 results
19/04SoftOx Solutions Concludes Early-stage Study Of Inhaled Antimicrobial Drug
19/04SOFTOX SOLUTIONS AS : Announces completion of last subject last visit in SIS project
01/03SOFTOX : Presentation as of February 28.2022
16/02SOFTOX : Open and Download Complete Fourth Quarter 2021 Report
16/02SOFTOX SOLUTIONS AS : Results for the fourth quarter 2021
15/02SOFTOX SOLUTIONS AS : Postponed webcast presentation of Q4 2021 results
08/02SOFTOX SOLUTIONS AS : Invitation to the presentation of the 4Q 2021 results
24/01SoftOx Withdraws Application for Disinfection Products Approval in Norway, to Reapply b..
24/01SOFTOX SOLUTIONS AS : Changes regarding application for national approval of disinfection ..
24/01SoftOx Solutions AS Announces Changes Regarding Application for National Approval of Di..
24/01SoftOx Moves To Next Dose Level In Early-Stage Study Of Chronic Wound Drug
24/01Softox biofilm eradicator study (sbe-01) advances to next dose level due to excellent s..
17/01SOFTOX SOLUTIONS AS : Cancellation of subsequent offering
01/01SOFTOX SOLUTIONS AS : New share capital registered
2021SOFTOX SOLUTIONS AS : Minutes from extraordinary general meeting
2021SOFTOX SOLUTIONS AS : Mandatory notification for close associate
2021SOFTOX SOLUTIONS AS : New share capital registered
2021SOFTOX SOLUTIONS AS : Notice of extraordinary general meeting
2021SOFTOX : Presentation as of Desember 08.2021
2021SOFTX : Ex. Right to receive subscription rights in potential repair offering
2021SOFTOX SOLUTIONS AS : Key information relating to potential repair offering
2021SOFTOX SOLUTIONS AS : Private placement successfully completed
2021SOFTOX SOLUTIONS AS : Contemplated private placement
2021SOFTOX : Morning Meeting Presentation for brokers at Sparebanken 1 Markets as of Desember ..
2021SOFTOX WINS SWEDISH TENDER FOR SURFA : "This is a milestone
2021SoftOx Solutions AS Wins Swedish Tender for Surface Disinfection
2021The EU Commission's interpretation of the Biocidal Regulations can allow SoftOx to ente..
2021SOFTOX SOLUTIONS AS : The Research Council of Norway grants NOK 2.4 million for the develo..
2021SOFTOX : Presentation as of November 17. 2021
2021SOFTOX : Report Third Quarter 2021
2021SOFTOX : Open and Download Complete Third Quarter 2021 Report
2021SOFTOX SOLUTIONS AS : Results for the third quarter 2021
2021SoftOx Solutions AS Reports Earnings Results for the Third Quarter and Nine Months Ende..
2021SOFTOX SOLUTIONS AS : The Ministry of Defence guarantees NOK 10.6 million in support in co..
2021SOFTOX SOLUTIONS AS : Invitation to Strategy and Capital Markets Day, including Q3 2021 re..
2021SoftOx Solutions AS Announces First Patient Enrolled in the Clinical Study for Softox W..
2021SOFTOX SOLUTIONS : First subject enrolled in trial of softox inhaled solution (sis)
2021SoftOx Solutions AS Announces First Subject Enrolled in Trial of Softox Inhaled Solutio..
2021SOFTOX SOLUTIONS AS : Strengthens the liquidity
2021SOFTOX SOLUTIONS : Approval received from danish medicines agency to commence first clinic..
2021Softox Solutions as Announces That the Danish Medicines Agency Approved the Phase 1 Cli..
2021SOFTOX SOLUTIONS AS : has received a response from the Ministry of Climate and Environment
2021SoftOx Solutions AS Receives Response from the Ministry of Climate and Environment
2021SOFTOX : Norway's Ministry Confirms Sales Deadline For SoftOx Solutions' Disinfection
2021SOFTOX SOLUTIONS AS : has received a response from the Ministry of Climate and Environment
2021SoftOx Solutions AS Receives A Response from the Ministry of Climate and Environment
2021SOFTOX SOLUTIONS AS : has received a response from the Norwegian Environment Agency (NEA) ..
2021Softox Solutions AS Receives Response from the Norwegian Environment Agency Regarding t..
2021SOFTOX : Presentation as of September 08. 2021
2021SOFTOX : Open and Download Complete Second Quarter 2021 Report
2021Softox Solutions as Reports Earnings Results for the Second Quarter Ended June 30, 2021
2021SOFTOX SOLUTIONS AS : Results for the second quarter and first half of 2021
2021SOFTOX SOLUTIONS AS : Secures production at a competitive price
2021SOFTOX SOLUTIONS AS : Invitation to presentation of second quarter and half year 2021 resu..
2021SOFTOX : Disinfectant Lands Norwegian National Tender; Shares Up 20%
2021SOFTOX : Wins national hospital tender for hand disinfectants
2021SOFTOX SOLUTIONS AS - PROJECT UPDATE : SoftOx Biofilm Eradicator (SBE)
2021SoftOx Solutions AS Provides Project Update on SoftOx Biofilm Eradicator
2021SoftOx Solutions as Has Submitted A New Application for National Approval for Its Disin..
2021SOFTOX SOLUTIONS AS : Swis-02 study results shows superior wound healing
2021SoftOx Solutions' SWIS-02 Study Results Shows Superior Wound Healing
2021SOFTOX : Gets Conditional Nod in Denmark to Start Human Study of Respiratory Therapy
2021SOFTOX SOLUTIONS AS : The Danish Medicines Agency has given a conditional approval for the..
2021Softox Solutions AS Announces that the Danish Medicines Agency Has Given Conditional Ap..
2021SOFTOX SOLUTIONS AS : First Quarter 2021 Results
Prochain événement sur SOFTOX SOLUTIONS AS